去氨基 deamination ; deaminization
使脱去氨基 deaminate
去氨加压素 Minirin ; DDAVP ; Desmopressin
去氨木香内酯 Dehydrocostus lactone
腺嘌呤去氨酵素缺损 Adenosine Deaminase Deficiency, ADA ; Adenosine Deaminase Deficiency
醋酸去氨加压素注射液 Minirin ; Desmopressin Acetate Injection
去氨基甲酰化常数 decarbamylation constant
醋酸去氨加压素 Desmopressin ; Desmopressin acetate
去甲氨噻肟酸乙酯 EHATA
目的了解和分析去氨加压素在临床应用中不良反应,促进临床合理用药。
Objective To study the adverse drug reaction (ADR) of desmopressin (DDAVP) in clinical application, improving clinical medication.
在经皮肾穿刺患者中,穿刺前给予去氨加压素减少出血风险、减少血肿大小,而不增加住院费用。
Prebiopsy desmopressin administration decreases the risk of bleeding and hematoma size in patients undergoing percutaneous kidney biopsy without a cost increase.
尽管这不是一个设有对照的试验,但研究者断定去氨加压素能安全有效地治疗65岁及65岁以上患者的重度夜尿症。
Although this was not a controlled trial, they concluded that desmopressin is "safe and effective in the treatment of severe nocturia in patients 65 years old and older."
应用推荐